ChemRobotics TimesTM
- Recent News Articles -
.
- FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection
- AgbioInvestor Global Ties with ChemRobotics
- The FDA has Approved TZIELDTM (Teplizumab-mzwv) as the First and Only Medication Intended to Postpone the onset of Stage 3 Type 1 Diabetes (T1D) in Adult and Paediatric Patients with Stage 2 T1D Who are 8 Years of Age and Older.
- Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)
- Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for relapsed or Refractory Multiple Myeloma
ChemRobotics TimesTM Newletter
Subscribe ChemRobotics TimessTM for Top Updates in the Agrochemical & Pharmaceutical Sectors!!!